Rakovina Therapeutics Inc (RKV)
TSXV
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 0 | 0 | 0 | 0 |
Operating Income | -145k | -2.06M | -2.4M | -2.17M |
Pre Tax Income | -191k | -5.52M | -2.79M | -2.61M |
Net Income | -191k | -5.52M | -2.79M | -2.61M |
Preferred Dividends | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.013 | -0.079 | -0.04 | -0.037 |
EBIT | -145k | -2.06M | -2.4M | -2.21M |
EBITDA | -145k | -1.65M | -1.86M | -1.63M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.